SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Sicilian patients with melanoma

Melanoma Research

Volumn 18, Issue 4, 2008, Pages 295-299

  Salemi, Michele ^a   Bosco, Paolo ^a   Calì, Francesco ^a   Calogero, Aldo E ^b   Soma, Pier Franco ^c   Galia, Antonio ^d   Lanzafame, Manuela ^c   Romano, Carmelo ^a   Vicari, Enzo ^b   Grasso, Giuseppe ^d   Siragò, Paolo ^c   Rappazzo, Giancarlo ^c  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b Section of Endocrinology   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d CANNIZZARO HOSPITAL   (Italy)

Author keywords

Melanoma; Sperm protein associated with the nucleus in the X chromosome B gene; Sperm protein associated with the nucleus in the X chromosome C gene; Xq27 region

Indexed keywords

CHROMOSOME PROTEIN; SPANX B PROTEIN; SPANX C PROTEIN; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; SPANXB1 PROTEIN, HUMAN; SPANXC PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHROMOSOME XQ; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; MALE; MELANOMA; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; GENETICS; ITALY; MIDDLE AGED; SKIN TUMOR;

AGED; GENE DOSAGE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; SICILY; SKIN NEOPLASMS;

EID: 58149377816     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32830aaa90     Document Type: Article

References (30)

1. De Vries E, Coebergh JW. Melanoma incidence has risen in Europe. BMJ 2005; 331:698.
2. Tumino R, Frasca G, Palli D, Masala G, Tagliabue G, Evangelista A, et al. Cancer incidence in EPIC-ITALY at first follow-up. Tumori 2003; 89: 656-664.
3. Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, et al. Recent segmental duplications in the human genome. Science 2002; 297:1003-1007.
4. Cheung J, Estivill X, Khaja R, MacDonald JR, Lau K, Tsui LC, Scherer SW. Genome-wide detection of segmental duplications and potential assembly errors in the human genome sequence. Genome Biol 2003; 4:R25.
5. Salemi M, Romano C, Ragusa L, Di Vita G, Salluzzo R, Oteri I, et al. A new 6-bp SOX3 polyalanine tract deletion does not segregate with mental retardation. Genetic Testing 2007; 11:124-127.
6. Salemi M, Calogero AE, Di Benedetto D, Cosentino A, Barone N, Rappazzo G, Vicari E. Expression of SPANX proteins in human-ejaculated spermatozoa and sperm precursors. Int J Androl 2004; 27:134-139.
7. Salemi M, Calogero AE, Castiglione R, Tricoli D, Asero P, Rosa R, et al. Expression of SpanX proteins in normal testes and in testicular germ cell tumours. Int J Androl 2006; 29:368-373.
8. Salemi M, Calogero AE, Bosco P, Castiglione R, La Vignera S, Borgione E, et al. Expression of SpanX mRNA in testicular germ cell tumors. Hum Cell 2006; 19:87-90.
9. Laumonnier F, Ronce N, Hamel BCJ, Thomas P, Lespinasse J, Raynaud M, et al. Transcription factor SOX3 is involved in X-Linked Mental Retardation with Growth Hormone Deficiency. Am J Hum Genet 2002;71:1450-1455.
10. Kouprina N, Mullokandov M, Rogozin I, Collins K, Solomon G, Otstot J, et al. The SPANX gene family of cancer-testis specific antigens: rapid evolution, an unusual case of positive selection and amplification in African Great Apes and hominids. Proc Natl Acad Sci 2004; 101: 3077-3082.
11. Westbrook VA, Diekman AB, Klotz KL, Khole VV, von Kap-Herr C, Golden WL, et al. Spermatid-specific expression of the novel X-linked gene product SPAN-X localized to the nucleus of human spermatozoa. Biol Reprod 2000; 63:469-481.
12. Zendman AJ, Zschocke J, van Kraats AA, de Wit NJ, Kurpisz M, Weidle UH, et al. The human SPANX multigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines. Gene 2003; 309:125-133.
13. Westbrook VA, Schoppee PD, Diekman AB, Klotz KL, Allietta M, Hogan KT, et al. Genomic organization, incidence, and localization of the SPAN-X family of cancer-testis antigens in melanoma tumors and cell lines. Clin Cancer Res 2004; 10:101-112.
14. Wang Z, Zhang Y, Liu H, Salati E, Chiriva-Internati M, Lim SH. Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood 2003; 101: 955-960.
15. Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, van Muijen GN. CTp11, a novel member of the family of human cancer/testis antigens. Cancer Res 1999; 59:6223-6229.
16. Kouprina N, Pavlicek A, Noskov VN, Solomon G, Otstot J, Isaacs W, et al. Dynamic structure of the SPANX gene cluster mapped to the prostate cancer susceptibility locus HPCX at Xq27. Genome Res 2005; 15: 1477-1486.
17. Chen YT, Rettig WJ, Yenamandra AK, Kozak CA, Chaganti RS, Posner JB, Old LJ. Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proc Natl Acad Sci 1990; 87:3077-3081.
18. Dropcho EJ, Chen YT, Posner JB, Old LJ. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci 1987; 84:4552-4556.
19. Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, Posner JB. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. New Engl J Med 1990; 322:1844-1851.
20. Nagasaki K, Manabe T, Hanzawa H, Maass N, Tsukada T, Yamaguchi K. Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett 1999; 140:227-234.
21. Anello G, Gueant J, Romano C, Barone C, Pettinato R, Pillot T, et al. Allele 4 of apolipoprotein E gene is less frequent in Down syndrome patient of the Sicilian population and has no influence on the grade of mental retardation. Neurosci Lett 2001; 306:129-131.
22. Rychlik W, Rhoads RE. A computer program for choosing optimal oligonucleotides for filter hybridization, sequencing and in vitro amplification of DNA. Nucleic Acids Res 1989; 17:8543-8551.
23. Yau SC, Mathew CG, Abbs S. A single PCR assay detects CMT1A duplications and HNPP deletions of PMP-22 gene. J Med Genet 1996; 33 (Suppl 1):S3A.
24. Rowland JS, Barton DE, Taylor GR. UK Clinical Molecular Genetics Society HMSN Project Group. A comparison of methods for gene dosage analysis in HMSN type 1. J Med Genet 2001; 38:90-95.
25. Di Bella MA, Cali F, Seidita G, Mirisola M, Ragusa A, Ragalmuto A, et al. Screening of subtelomeric rearrangements in autistic disorder: identification of a partial trisomy of 13q34 in a patient bearing a 13q;21p translocation. Am J Med Genet B Neuropsychiatr Genet 2006; 141:584-590.
26. Koolen DA, Nillesen WM, Versteeg MH, Merkx GF, Knoers NV, Kets M, et al. Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA). J Med Genet 2004; 41:892-899.
27. Sharp AJ, Locke DP, McGrath SD, Cheng Z, Bailey JA, Vallente RU, et al. Segmental duplications and copy-number variation in the human genome. Am J Hum Genet 2005; 77:78-88.
28. Shaw CJ, Lupski JR. Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 2004; 1:R57-R64.
29. Chen YT, Gure AO, Tsang S, Stockert E, Jäger E, Knuth A, Old LJ. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci U S A 1998; 95:6919-6923.
30. Lucas S, De Plaen E, Boon T. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: four new members of the MAGE family with tumor-specific expression. Int J Cancer 2000; 87:55-60.